Meeder Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-355
| Closed | -$2K | – | 2645 |
|
|
2019
Q4 | $2K | Buy |
+355
| New | +$2K | ﹤0.01% | 2087 |
|
|
2019
Q3 | – | Sell |
-1,883
| Closed | -$11K | – | 2326 |
|
|
2019
Q2 | $11K | Buy |
1,883
+1,449
| +334% | +$8.47K | ﹤0.01% | 1439 |
|
|
2019
Q1 | $6K | Buy |
434
+112
| +35% | +$1.55K | ﹤0.01% | 1377 |
|
|
2018
Q4 | $3K | Buy |
+322
| New | +$3K | ﹤0.01% | 1545 |
|
|
2018
Q1 | – | Sell |
-230
| Closed | -$5K | – | 1814 |
|
|
2017
Q4 | $5K | Sell |
230
-7
| -3% | -$152 | ﹤0.01% | 1337 |
|
|
2017
Q3 | $10K | Sell |
237
-317
| -57% | -$13.4K | ﹤0.01% | 1086 |
|
|
2017
Q2 | $17K | Hold |
554
| – | – | ﹤0.01% | 867 |
|
|
2017
Q1 | $20K | Sell |
554
-275
| -33% | -$9.93K | ﹤0.01% | 728 |
|
|
2016
Q4 | $42K | Buy |
+829
| New | +$42K | ﹤0.01% | 584 |
|
|
2016
Q3 | – | Sell |
-6,480
| Closed | -$268K | – | 1011 |
|
|
2016
Q2 | $268K | Buy |
+6,480
| New | +$268K | 0.03% | 530 |
|
|
2016
Q1 | – | Sell |
-462
| Closed | -$19K | – | 960 |
|
|
2015
Q4 | $19K | Buy |
+462
| New | +$19K | ﹤0.01% | 743 |
|